Search - tctmd.com

Displaying 1 - 20 of 247

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms

Michael O'Riordan

August 20, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Conference News ACC 2025

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

Michael O'Riordan

April 04, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

News Daily News

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Michael O'Riordan

December 23, 2024

News Conference News PCR London Valves 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

News Conference News NY Valves 2024

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Michael O'Riordan

June 06, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Pi-Cardia Reports First Commercial Cases with ShortCut™

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

National Data Point to Soaring TAVI Rates in Patients Under 65

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content